Based on epidemiological estimates, the prevalence of diabetes (DM) is increasing every year, and it also increases with age, thus forecasting a poor scenario for the coming decades. At the same time, treatment for the frail elderly population has not received attention and clinical trials on this population are scarce. Thus, older adults with diabetes can be fit and healthy or frail with many comorbidities and functional disabilities. Most current guidelines and consensus documents lack specific treatments for the older patient [1].
